Paid Clinical Trials Paid Clinical Trials > Browse Categories > Mental Health Disorders > Psychotic Disorders > Schizoaffective Disorder

Schizoaffective Disorder

Schizoaffective Disorder

All Categories Mental Health Disorders » Psychotic Disorders » Schizoaffective Disorder


  • Randomized Double Blind Placebo Control Study in Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Psychosis Not Otherwise Specified;   Schizophreniform Disorder
    Interventions:   Drug: Ondanstron;   Drug: Simvastatin;   Drug: Placebo
    Sponsors:   Pakistan Institute of Learning and Living;   Pakistan Institute of Learning and Living;   Stanley Medical Research Institute;   Pakistan Institute of Learning & Living;   Dow University of Health Sciences;   Karwane Hayat;   Abbasi Shaheed Hospital
    Recruiting - verified May 2012
  • Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients

    Conditions:   Oxytocin + Non Specific Counselling;   Oxytocin + Social Skills Training;   Placebo + Non Specific Counselling;   Placebo + Social Skills Training
    Interventions:   Drug: Oxytocin;   Behavioral: Social Skills Training;   Behavioral: Placebo + Non Specific Counselling
    Sponsors:   Sheba Medical Center;   Sheba Medical Center
    Not yet recruiting - verified May 2012
  • A Safety and Pharmacokinetic Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: risperidone-SABER;   Other: ZX003:risperidone-SABER and the DosePro System;   Drug: risperidone-SABER
    Sponsors:   Zogenix, Inc.;   Zogenix, Inc.
    Not yet recruiting - verified May 2012
  • Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Drug: salsalate
    Sponsors:   Massachusetts General Hospital;   Massachusetts General Hospital;   National Institutes of Health (NIH)
    Recruiting - verified April 2012
  • Oxytocin as Adjunctive Treatment of Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsors:   Emory University;   Emory University;   Atlanta VA Medical Center
    Not yet recruiting - verified March 2012
  • Brain Imaging, Cognitive Enhancement and Early Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Behavioral: Cognitive Enhancement Therapy;   Behavioral: Enriched Supportive Therapy
    Sponsors:   Beth Israel Deaconess Medical Center;   Beth Israel Deaconess Medical Center;   University of Pittsburgh;   Massachusetts General Hospital;   Massachusetts Institute of Technology
    Not yet recruiting - verified March 2012
  • Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients

    Conditions:   Schizophrenia;   Schizo-affective Disorder
    Intervention:   Behavioral: Implementation Intentions
    Sponsors:   University of Konstanz;   University of Konstanz;   Center for Psychiatry, Reichenau, Germany;   Thurgau Psychiatric Services, Switzerland
    Not yet recruiting - verified March 2012
  • First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Drug: AMG 579;   Drug: Placebo
    Sponsors:   Amgen;   Amgen
    Recruiting - verified March 2012
  • PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)

    Conditions:   Post Traumatic Stress Disorder;   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Major Depression
    Interventions:   Behavioral: PE + TAU;   Behavioral: Treatment As Usual
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs;   University of Hawaii
    Not yet recruiting - verified April 2012
  • Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: DAR-100A;   Drug: Placebo
    Sponsors:   New York State Psychiatric Institute;   New York State Psychiatric Institute
    Recruiting - verified January 2012
  • Cognitive Remediation in Early Phase Psychosis

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Psychosis NOS
    Intervention:   Behavioral: Cognitive remediation
    Sponsors:   Oslo University Hospital;   Oslo University Hospital;   Stiftelsen Helse og Rehabilitering;   South-Eastern Norway Regional Health Authority
    Recruiting - verified March 2012
  • RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

    Conditions:   Acute Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: RP5063;   Drug: placebo;   Drug: RP5063;   Drug: RP5063;   Drug: aripiprazole
    Sponsors:   Reviva Pharmaceuticals;   Reviva Pharmaceuticals
    Recruiting - verified December 2011
  • Effectiveness of Cognitive Remediation in a Supported Education Setting

    Condition:   Psychosis
    Interventions:   Behavioral: Cognitive Remediation;   Behavioral: Supported Education
    Sponsors:   Centre for Addiction and Mental Health;   Centre for Addiction and Mental Health;   George Brown College
    Recruiting - verified February 2012
  • Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
    Interventions:   Drug: Raloxifene Hydrochloride;   Drug: Placebo
    Sponsors:   The Alfred;   The Alfred
    Recruiting - verified January 2012
  • Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder With Psychotic Features;   Major Depression With Psychotic Features
    Interventions:   Behavioral: Group Cognitive Behavioral Therapy;   Behavioral: Multifamily Group Psychoeducation
    Sponsors:   University of Arizona;   University of Arizona
    Recruiting - verified April 2012
  • Proof-of-Concept Study of Pipamperone Added to Continued Depot Antipsychotic Treatment in Chronic Schizophrenia

    Conditions:   Chronic Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Pipamperone;   Drug: sugar pill
    Sponsors:   PharmaNeuroBoost N.V.;   PharmaNeuroBoost N.V.
    Recruiting - verified March 2012
  • N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: D-serine;   Drug: placebo;   Behavioral: Sensory Based remediation paradigm
    Sponsors:   Nathan Kline Institute for Psychiatric Research;   Nathan Kline Institute for Psychiatric Research;   Columbia University
    Not yet recruiting - verified July 2011
  • Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia

    Condition:   Schizophrenia (Recent-onset)
    Interventions:   Drug: paliperidone palmitate;   Drug: risperidone
    Sponsors:   National Institute of Mental Health (NIMH);   National Institute of Mental Health (NIMH);   Ortho-McNeil Janssen Scientific Affairs, LLC
    Not yet recruiting - verified October 2011
  • Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen

    Conditions:   Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder
    Intervention:   Drug: Amisulpride
    Sponsors:   University of Copenhagen;   Birte Glenthoj;   Glostrup University Hospital, Copenhagen;   Rigshospitalet, Denmark;   Institute of Psychiatry, London;   UMC Utrecht;   Copenhagen Hospital Corporation
    Recruiting - verified March 2012
  • Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Placebo;   Drug: Melatonin
    Sponsors:   University of Copenhagen;   Lone Baandrup;   Glostrup University Hospital, Copenhagen;   Copenhagen Trial Unit, Center for Clinical Intervention Research
    Recruiting - verified October 2011
  • Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
    Intervention:  
    Sponsors:   University of Maryland;   University of Maryland;   National Institutes of Health (NIH)
    Recruiting - verified March 2012
  • Brain Circuits in Schizophrenia and Smoking

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
    Intervention:  
    Sponsors:   University of Maryland;   University of Maryland;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified August 2011
  • Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Behavioral: Visual Decision Aid and Shared Decision Making Model;   Behavioral: Usual Care
    Sponsors:   VA Nebraska Western Iowa Health Care System;   VA Nebraska Western Iowa Health Care System;   New England MIRECC;   Nebraska Educational Biomedical Research Association
    Recruiting - verified August 2011
  • F-18 Altanserin PET Study of Patients Receiving Clozapine

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Drug: clozapine
    Sponsors:   Seoul National University Bundang Hospital;   Seoul National University Bundang Hospital
    Recruiting - verified January 2012
  • Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Drug: Intranasal Oxytocin Spray
    Sponsors:   University of North Carolina, Chapel Hill;   University of North Carolina, Chapel Hill;   National Institute of Mental Health (NIMH)
    Recruiting - verified November 2011
  • A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

    Conditions:   Schizophrenia;   Schizoaffective Disorders
    Intervention:   Drug: olanzapine
    Sponsors:   Shalvata Mental Health Center;   Shalvata Mental Health Center
    Recruiting - verified June 2011
  • Database Registry to Examine Brain Connections and Brain Function in Mental Disorders

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:  
    Sponsors:   University of Texas Southwestern Medical Center;   University of Texas Southwestern Medical Center;   National Institute of Mental Health (NIMH)
    Recruiting - verified June 2011
  • Neurophysiological Studies in Schizophrenia and Psychiatric Disorders

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder
    Intervention:  
    Sponsors:   University of Texas Southwestern Medical Center;   University of Texas Southwestern Medical Center;   National Institute of Mental Health (NIMH)
    Recruiting - verified May 2011
  • Brain Health and Exercise in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Poor Memory
    Intervention:  
    Sponsors:   BC Mental Health and Addictions Research Institute;   BC Mental Health and Addictions Research Institute;   University of British Columbia;   Simon Fraser University;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified January 2011
  • The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels

    Conditions:   Bipolar Affective Disorders;   Cyclothymic Disorder;   Schizoaffective Disorder;   Major Depressive Disorder;   Dysthymic Disorder;   Obsessive-Compulsive Disorder;   Panic Disorder;   Posttraumatic Stress Disorder;   Premenstrual Dysphoric Disorder;   Social Anxiety Disorder
    Intervention:  
    Sponsors:   Weill Medical College of Cornell University;   Weill Medical College of Cornell University
    Recruiting - verified June 2011
  • The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia

    Conditions:   Schizophrenia;   Psychotic Disorder NOS;   Schizoaffective Disorder;   Schizophreniform
    Interventions:   Drug: N-Acetyl Cysteine;   Other: sugar pill
    Sponsors:   Indiana University;   Indiana University;   Stanley Medical Research Institute;   Indiana University School of Medicine;   The Brain Research Foundation
    Recruiting - verified April 2012
  • An Integrated Program for the Treatment of First Episode of Psychosis

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Brief Psychotic Disorder;   Psychotic Disorder NOS
    Interventions:   Behavioral: Integrated Treatment;   Behavioral: Community Care
    Sponsors:   North Shore Long Island Jewish Health System;   North Shore Long Island Jewish Health System;   State University of New York - Downstate Medical Center;   University of North Carolina, Chapel Hill;   University of California, Los Angeles;   Dartmouth-Hitchcock Medical Center;   Research Foundation for Mental Hygiene;   National Institute of Mental Health (NIMH)
    Recruiting - verified January 2012
  • Reducing Internalized Stigma in People With Serious Mental Illness

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Major Depression With Psychotic Features
    Interventions:   Behavioral: Ending Self Stigma (ESS);   Behavioral: Health and Wellness Group
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs
    Recruiting - verified May 2012
  • Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychosis
    Intervention:   Behavioral: Multi-element, team-oriented treatment
    Sponsors:   Research Foundation for Mental Hygiene;   Research Foundation for Mental Hygiene;   National Institute of Mental Health (NIMH);   University of Maryland;   New York State Office of Mental Health (OMH);   Maryland Department of Health and Mental Hygiene
    Recruiting - verified January 2012
  • Effectiveness of Ziprasidone for Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Drug: Ziprasidone
    Sponsors:   Soonchunhyang University Hospital;   Soonchunhyang University Hospital;   Pfizer
    Recruiting - verified July 2011
  • Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

    Conditions:   Recent-Onset Psychosis;   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder With Psychotic Features;   Major Depression With Psychotic Features;   Psychosis NOS
    Interventions:   Behavioral: Multifamily Group Psychoeducation (MFG);   Behavioral: Cognitive Remediation (CR)
    Sponsors:   University of Arizona;   University of Arizona;   Institute for Mental Health Research
    Recruiting - verified November 2011
  • Study of Vitamin D in the Severely Mentally Ill

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Dietary Supplement: Vitamin D3;   Dietary Supplement: Vitamin D3
    Sponsors:   Bronx Psychiatric Center;   Bronx Psychiatric Center
    Recruiting - verified April 2012
  • A Comparison of Long-acting Injectable Medications for Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: haloperidol decanoate;   Drug: paliperidone palmitate
    Sponsors:   New York State Psychiatric Institute;   New York State Psychiatric Institute;   National Institute of Mental Health (NIMH);   Duke University;   University of North Carolina, Chapel Hill
    Recruiting - verified January 2012
  • Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Chronic Residual Schizophrenia

    Conditions:   Schizoaffective and Schizophreniform Disorders;   Schizophrenia
    Interventions:   Drug: Ondansetron;   Drug: Placebo
    Sponsors:   Bayside Health;   Bayside Health
    Recruiting - verified October 2011
  • Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Drug: Varenicline
    Sponsors:   Centre for Addiction and Mental Health;   Centre for Addiction and Mental Health;   Pfizer
    Recruiting - verified March 2012
  • Factors Association With Poor Physical Function in Older Adults With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:  
    Sponsors:   University of California, San Francisco;   University of California, San Francisco;   National Institute of Nursing Research (NINR)
    Recruiting - verified April 2012
  • Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorders;   Schizophreniform Disorders
    Interventions:   Drug: Pravastatin;   Drug: Placebo
    Sponsors:   Massachusetts General Hospital;   Massachusetts General Hospital;   Stanley Medical Research Institute;   North Suffolk Mental Health Association
    Recruiting - verified April 2012
  • Prevention of Weight Gain in Early Psychoses

    Conditions:   Schizophreniform Disorder;   Bipolar Disorder (Type I);   Bipolar Disorder (Type 2);   Major Depressive Disorder With Psychotic Features,;   Substance-Induced Psychoses;   Psychosis Not-Otherwise-Specified (NOS);   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Behavioral: Behavioural Intervention for the Prevention of Weight Gain
    Sponsors:   Centre for Addiction and Mental Health;   Centre for Addiction and Mental Health;   Canadian Institutes of Health Research (CIHR)
    Recruiting - verified February 2012
  • Cognitive Skills Training Using Computer for Patients With Severe Mental Illness

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Behavioral: Computerized Cognitive Skill Training;   Behavioral: CRT and Social Cognition
    Sponsors:   Nathan Kline Institute for Psychiatric Research;   Nathan Kline Institute for Psychiatric Research
    Recruiting - verified June 2011
  • Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2

    Conditions:   Diabetes;   Obesity;   Weight Gain
    Intervention:   Behavioral: Behavioral Weight Loss Program
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs
    Recruiting - verified December 2011
  • Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Telmisartan;   Drug: Placebo
    Sponsors:   Massachusetts General Hospital;   Massachusetts General Hospital;   National Institutes of Health (NIH)
    Recruiting - verified April 2012
  • Smoking Cessation for Veterans With Severe and Persistent Mental Illness

    Conditions:   Schizoaffective Disorder;   Schizophrenia;   Mood Disorders With Psychotic Features
    Interventions:   Behavioral: BTSCS;   Behavioral: StSST
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs
    Recruiting - verified December 2011
  • Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

    Conditions:   Schizophrenia;   Dual Diagnosis;   Schizoaffective Disorder;   Psychotic Disorder;   Cannabis Use Disorder
    Interventions:   Drug: Dronabinol;   Drug: Cannabis
    Sponsors:   Dartmouth-Hitchcock Medical Center;   Dartmouth-Hitchcock Medical Center;   National Institute on Drug Abuse (NIDA);   Indiana University;   Columbia University;   University of Vermont;   University of Massachusetts, Worcester
    Recruiting - verified January 2012
  • Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

    Conditions:   Schizoaffective Disorder;   Schizophrenia
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Mental Health (NIMH)
    Recruiting - verified February 2012
  • Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia

    Condition:   Tardive Dyskinesia
    Interventions:   Drug: Pyridoxal 5'-Phosphate;   Drug: Placebo
    Sponsors:   Medicure;   Medicure
    Recruiting - verified September 2011
  • Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
    Intervention:   Drug: risperidone
    Sponsors:   Centre for Addiction and Mental Health;   Centre for Addiction and Mental Health
    Recruiting - verified April 2012
  • Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
    Interventions:   Behavioral: Cognitive-Behavior Therapy;   Other: Standard Psychiatric Treatment
    Sponsors:   New York State Psychiatric Institute;   New York State Psychiatric Institute;   National Institute of Mental Health (NIMH)
    Recruiting - verified December 2011
  • Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Dietary Supplement: Pregnenolone;   Dietary Supplement: Placebo
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs
    Recruiting - verified March 2012
  • Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder;   Delusional Disorder;   Psychotic Disorder
    Intervention:   Drug: Risperidone/Olanzapine and PET scans
    Sponsors:   Centre for Addiction and Mental Health;   Centre for Addiction and Mental Health
    Recruiting - verified April 2012
  • Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain in Adolescents and Young Adults

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Schizophreniform;;   Bipolar I Disorder;   Bipolar II;   Bipolar NOS;   Psychotic Disorder Not Otherwise Specified;   Autism
    Intervention:   Drug: Betahistine
    Sponsors:   Nathan Kline Institute for Psychiatric Research;   Nathan Kline Institute for Psychiatric Research;   Stanley Medical Research Institute
    Recruiting - verified June 2011
  • Cognitive-Behavioral Therapy in Veterans With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Other: supportive therapy;   Other: cognitive-behavioral therapy for psychosis
    Sponsors:   Department of Veterans Affairs;   Department of Veterans Affairs
    Recruiting - verified December 2011
  • Study to Demonstrate Cognitive Enhancing Effects of BF2.649

    Condition:   Schizophrenia
    Interventions:   Drug: BF2.649;   Drug: Placebo
    Sponsors:   University of Texas Southwestern Medical Center;   University of Texas Southwestern Medical Center;   Bioprojet;   Stanley Medical Research Institute
    Recruiting - verified June 2010
  • Efficacy of Pregnenolone in Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Dietary Supplement: placebo pregnenolone;   Dietary Supplement: pregnenolone
    Sponsors:   Weill Medical College of Cornell University;   Weill Medical College of Cornell University;   Stanley Medical Research Institute
    Recruiting - verified July 2011
  • Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations

    Condition:   Schizophrenia
    Interventions:   Device: Magstim Rapid 2 system triggering Magstim Super Rapid system;   Device: Magstim Rapid-2 system triggering Magstim Super Rapid system
    Sponsors:   Yale University;   Yale University;   National Institute of Mental Health (NIMH)
    Recruiting - verified March 2012
  • Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Bipolar Disorder;   Obesity;   Metabolic Syndrome
    Intervention:   Drug: olanzapine and melatonin
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   Seattle Institute for Biomedical and Clinical Research;   Eli Lilly and Company
    Recruiting - verified November 2011
  • Zyprexa and Task Engagement in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Olanzapine (Zyprexa);   Drug: Typicals
    Sponsors:   VA Connecticut Healthcare System;   VA Connecticut Healthcare System;   Clinical Trials Network of Columbia U, Cornell U, and NY Presbyterian Hospital;   Eli Lilly and Company
    Recruiting - verified March 2012
  • Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Intervention:   Drug: modafinil
    Sponsors:   University of California, Davis;   University of California, Davis
    Recruiting - verified August 2011
  • Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Behavioral: Cognitive remediation;   Behavioral: Health behavior training;   Drug: Risperidone, administered orally;   Drug: Risperidone, administered via injection;   Behavioral: Individual Placement and Support
    Sponsors:   National Institute of Mental Health (NIMH);   National Institute of Mental Health (NIMH);   Ortho-McNeil Janssen Scientific Affairs, LLC
    Recruiting - verified October 2011
  • Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

    Condition:   Schizophrenia
    Interventions:   Behavioral: Group Skills Training and Psychoeducation;   Behavioral: Individual Case Management;   Drug: Oral Risperidone;   Drug: Risperidone in Long-Acting Injectable Form (Consta)
    Sponsors:   National Institute of Mental Health (NIMH);   National Institute of Mental Health (NIMH);   Ortho-McNeil Janssen Scientific Affairs, LLC
    Recruiting - verified October 2011
  • Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis

    Condition:   Schizophrenia
    Interventions:   Drug: Aripiprazole;   Drug: Risperidone;   Drug: Clozapine
    Sponsors:   North Shore Long Island Jewish Health System;   North Shore Long Island Jewish Health System;   National Institute of Mental Health (NIMH)
    Recruiting - verified January 2012
  • Coronary Artery Disease (CAD) Risk in Schizophrenia: Effect of Omega-3 Fatty Acid Supplementation

    Conditions:   Schizophrenia;   Schizoaffective Disorder;   Major Depression;   Bipolar Disorder;   Coronary Artery Disease
    Interventions:   Drug: Eicosapentaenoic acid (omega-3 fatty acid);   Drug: Placebo
    Sponsors:   University of Pittsburgh;   University of Pittsburgh;   American Heart Association;   VA Pittsburgh Healthcare System
    Recruiting - verified October 2011
  • Effects of Modafinil on Brain Function in Patients With Schizophrenia

    Conditions:   Schizophrenia;   Schizoaffective Disorder
    Interventions:   Drug: Modafinil;   Procedure: Functional MRI;   Procedure: Neuropsychological Testing
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Mental Health (NIMH)
    Recruiting - verified June 2011
  • Screening for Childhood-Onset Psychotic Disorders

    Conditions:   Childhood Onset Psychotic Disorders;   Schizophrenia
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Mental Health (NIMH)
    Recruiting - verified September 2011
  • Genetic Study of Schizophrenia

    Conditions:   Psychotic Disorder;   Schizoaffective Disorder;   Schizophrenia
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Mental Health (NIMH)
    Recruiting - verified March 2012
  • Inpatient Evaluation of Adults With Schizophrenia

    Conditions:   Psychotic Disorder;   Schizophrenia;   Schizoaffective;   Paranoia;   Psychosis
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Mental Health (NIMH)
    Recruiting - verified June 2011
  • Evaluation of the Genetics of Bipolar Disorder

    Conditions:   Mania;   Bipolar, Disorder;   Depression;   Mood Disorder;   Schizoaffective;   Manic Depression
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Mental Health (NIMH)
    Recruiting - verified December 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations